Canada's Biocure Technology Inc. said Marco Nonni resigned as a director.
Nonni joined the company's board in April, and will continue working with Biocure Technology on a consulting basis.
The company appointed Hans Frykman to replace Nonni, effective Sept. 4.
Frykman is medical director at Neurocode Labs and UBC Diagnostic Services Lab.
Biocure Technology develops and commercializes biosimilar pharmaceutical products in South Korea.